StockData
Viatris Inc logo

Viatris Inc

VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/303% below fair value
$19.63−0.25 (-1.26%)

Close on Nov 20, 2026Market cap $22.55BP/E –Yield 2.45%

Viatris Unrecognized Tax Benefits (UTB) Ending Balance by Year

Unrecognized Tax Benefits (UTB) Ending Balance ($M)

Viatris Unrecognized Tax Benefits (UTB) Ending Balance: $263M in FY2025, up 2.9% from a year earlier.

Latest, FY2025
263
Period ended Dec 31, 2025
Change on a year earlier
+2.9%
256 in FY2024
History
11 years
Since FY2015
Sources
6
Documents cited below

Where the FY2025 figure comes from

Source: SEC Form 10-K (2026-02-26) ↗

Reported in SEC Form 10-K Income Taxes Note.

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUnrecognized Tax Benefits (UTB) Ending Balance ($M)Year on yearSource
FY2025Dec 31, 2025263+2.9%SEC Form 10-K (2026-02-26) ↗
FY2024Dec 31, 2024256-6.3%SEC Form 10-K (2026-02-26) ↗
FY2023Dec 31, 2023273-8.1%SEC Form 10-K (2026-02-26) ↗
FY2022Dec 31, 2022297-8.1%SEC Form 10-K (2026-02-26) ↗
FY2021Dec 31, 2021323-17.4%SEC Form 10-K (2025-02-27) ↗
FY2020Dec 31, 2020391+324.6%SEC Form 10-K (2024-02-28) ↗
FY2019Dec 31, 201992.1-4.4%SEC Form 10-K (2022-02-28) ↗
FY2018Dec 31, 201896.3+4.6%SEC Form 10-K (2021-03-01) ↗
FY2017Dec 31, 201792.1-4.4%SEC Form 10-K (2023-02-27) ↗
FY2016Dec 31, 201696.3-48.1%SEC Form 10-K (2022-02-28) ↗
FY2015Dec 31, 2015186–SEC Form 10-K (2021-03-01) ↗

Cite this data

StockData. (2026). Viatris Unrecognized Tax Benefits (UTB) Ending Balance ($M), annual FY2015–FY2025 [Data set]. Compiled from Viatris SEC filings and investor materials. https://stockdatahq.com/stocks/vtrs/kpis/utb-balance

See every metric in the Viatris KPI table. Data updated Nov 16, 2026.

See a number that looks wrong?